Genomictree Inc. (KOSDAQ:228760)
South Korea · Delayed Price · Currency is KRW 13,270
-120 (-0.90%)
Jul 18, 2025, 3:30 PM KST
Genomictree Company Description
Genomictree Inc., a biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases.
The company offers EarlyTect C, a screening method for early diagnosis of colorectal cancer; EarlyTect L for detection of epigenetic markers associated with lung cancer in pulmonary nodule patients; and EarlyTect B for detection of genetic and epigenetic markers associated with bladder cancer in hematuria patients.
It also provides AccuraDTect SARS-CoV-2 RT-qPCR kits, test providers, and nucleic acid transport medium products.
The company was founded in 2000 and is headquartered in Daejeon, South Korea.
Genomictree Inc.
| Country | South Korea |
| Founded | 2000 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Sung-Whan An |
Contact Details
Address: 44-6 Techno 10-ro Daejeon, 34027 South Korea | |
| Phone | 82 4 2861 4551 |
| Website | genomictree.com |
Stock Details
| Ticker Symbol | 228760 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7228760005 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Sung-Whan An | Chief Executive Officer |
| Hong Sun Lee | Chief Financial Officer |
| Chi-Wang Yoon | Chief Operating Officer |